SG Americas Securities LLC lifted its holdings in shares of MEDNAX Inc (NYSE:MD) by 402.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 20,782 shares of the company’s stock after purchasing an additional 16,644 shares during the period. SG Americas Securities LLC’s holdings in MEDNAX were worth $1,111,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in MD. Prudential Financial Inc. increased its stake in MEDNAX by 976.9% in the third quarter. Prudential Financial Inc. now owns 641,057 shares of the company’s stock valued at $27,642,000 after acquiring an additional 581,527 shares during the last quarter. Quantbot Technologies LP bought a new position in MEDNAX in the third quarter valued at approximately $695,000. Point72 Asset Management L.P. increased its stake in MEDNAX by 71.7% in the third quarter. Point72 Asset Management L.P. now owns 132,700 shares of the company’s stock valued at $5,722,000 after acquiring an additional 55,400 shares during the last quarter. Nomura Holdings Inc. bought a new position in MEDNAX in the second quarter valued at approximately $347,000. Finally, Advisor Group Inc. increased its stake in MEDNAX by 41.9% in the third quarter. Advisor Group Inc. now owns 8,361 shares of the company’s stock valued at $359,000 after acquiring an additional 2,468 shares during the last quarter. 95.22% of the stock is currently owned by institutional investors.

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of MEDNAX from $46.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday. Jefferies Group reissued a “hold” rating and issued a $44.00 price objective on shares of MEDNAX in a research note on Friday, November 3rd. Mizuho reissued a “neutral” rating and issued a $53.00 price objective (up from $49.00) on shares of MEDNAX in a research note on Friday, February 9th. BMO Capital Markets lifted their price objective on shares of MEDNAX from $46.00 to $58.00 and gave the company a “market perform” rating in a research note on Monday. Finally, Stephens set a $62.00 price objective on shares of MEDNAX and gave the company a “buy” rating in a research note on Thursday, February 8th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the company. MEDNAX presently has a consensus rating of “Hold” and an average price target of $54.92.

Shares of MEDNAX Inc (NYSE MD) opened at $53.99 on Wednesday. MEDNAX Inc has a 52-week low of $40.56 and a 52-week high of $72.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.43 and a quick ratio of 1.37. The firm has a market cap of $5,093.91, a P/E ratio of 17.32, a price-to-earnings-growth ratio of 1.48 and a beta of 0.31.

MEDNAX (NYSE:MD) last issued its earnings results on Thursday, February 8th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.04. MEDNAX had a net margin of 9.26% and a return on equity of 10.10%. The firm had revenue of $910.82 million for the quarter, compared to analyst estimates of $884.55 million. During the same quarter last year, the business posted $1.00 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. equities research analysts expect that MEDNAX Inc will post 3.67 EPS for the current fiscal year.

In other MEDNAX news, insider John C. Pepia sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $51.58, for a total value of $154,740.00. Following the sale, the insider now owns 35,569 shares in the company, valued at $1,834,649.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.40% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2018/02/14/sg-americas-securities-llc-acquires-16644-shares-of-mednax-inc-md.html.

MEDNAX Profile

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MEDNAX Inc (NYSE:MD).

Institutional Ownership by Quarter for MEDNAX (NYSE:MD)

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.